Impact of Frailty Markers for Unplanned Hospital Readmission Following Transcatheter Aortic Valve Implantation
Tóm tắt
Từ khóa
Tài liệu tham khảo
1. Afilalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA, et al. Frailty assessment in the cardiovascular care of older adults. <i>J Am Coll Cardiol</i> 2014; 638: 747–762.
2. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. <i>N Engl J Med</i> 2012; 366: 1696–1704.
3. Lindman BR, Alexander KP, O’Gara PT, Afilalo J. Futility, benefit, and transcatheter aortic valve replacement. <i>JACC Cardiovasc Interv</i> 2014; 7: 707–716.
4. Green P, Woglom AE, Genereux P, Daneault B, Paradis JM, Schnell S, et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: A single-center experience. <i>JACC Cardiovasc Interv</i> 2012; 5: 974–981.
5. Stortecky S, Schoenenberger AW, Moser A, Kalesan B, Jüni P, Carrel T, et al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. <i>JACC Cardiovasc Interv</i> 2012; 5: 489–496.
6. Huded CP, Huded JM, Friedman JL, Benck LR, Lindquist LA, Holly TA, et al. Frailty status and outcomes after transcatheter aortic valve implantation. <i>Am J Cardiol</i> 2016; 117: 1966–1971.
7. Shimura T, Yamamoto M, Kano S, Kagase A, Kodama A, Koyama Y, et al. Impact of the clinical frailty scale on outcomes after transcatheter aortic valve replacement. <i>Circulation</i> 2017; 135: 2013–2024.
8. Okoh AK, Chauhan D, Kang N, Haik N, Merlo A, Cohen M, et al. The impact of frailty status on clinical and functional outcomes after transcatheter aortic valve replacement in nonagenarians with severe aortic stenosis. <i>Catheter Cardiovasc Interv</i> 2017; 90: 1000–1006.
9. Kleczynski P, Dziewierz A, Bagienski M, Rzeszutko L, Sorysz D, Trebacz J, et al. Impact of frailty on mortality after transcatheter aortic valve implantation. <i>Am Heart J</i> 2017; 185: 52–58.
10. Kleczynski P, Dziewierz A, Bagienski M, Rzeszutko L, Sorysz D, Trebacz J, et al. Long-term mortality and quality of life after transcatheter aortic valve insertion in very elderly patients. <i>J Invasive Cardiol</i> 2016; 28: 492–496.
11. Shimura T, Yamamoto M, Kano S, Kagase A, Kodama A, Koyama Y, et al. Impact of frailty markers on outcomes after transcatheter aortic valve replacement: Insights from a Japanese multicenter registry. <i>Ann Cardiothorac Surg</i> 2017; 6: 532–537.
12. Chauhan D, Haik N, Merlo A, Haik BJ, Chen C, Cohen M, et al. Quantitative increase in frailty is associated with diminished survival after transcatheter aortic valve replacement. <i>Am Heart J</i> 2016; 182: 146–154.
13. Nombela-Franco L, del Trigo M, Morrison-Polo G, Veiga G, Jimenez-Quevedo P, Abdul-Jawad Altisent O, et al. Incidence, causes, and predictors of early (≤30 days) and late unplanned hospital readmissions after transcatheter aortic valve replacement. <i>JACC Cardiovasc Interv</i> 2015; 8: 1748–1757.
14. Wahl TS, Graham LA, Hawn MT, Richman J, Hollis RH, Jones CE, et al. Association of the modified frailty index with 30-day surgical readmission. <i>JAMA Surg</i> 2017; 152: 749–757.
15. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. <i>N Engl J Med</i> 1995; 332: 556–561.
16. Shinkai S, Watanabe N, Yoshida H, Fujiwara Y, Nishi M, Fukaya T, et al. Validity of the “Kaigo-Yobo Check-List” as a frailty index. <i>Nihon Koshu Eisei Zasshi</i> 2013; 60: 262–274.
17. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. <i>J Am Coll Cardiol</i> 2012; 60: 1438–1454.
18. Afilalo J, Lauck S, Kim DH, Lefèvre T, Piazza N, Lachapelle K, et al. Frailty in older adults undergoing aortic valve replacement: The FRAILTY-AVR Study. <i>J Am Coll Cardiol</i> 2017; 70: 689–700.
19. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: Evidence for a phenotype. <i>J Gerontol A Biol Sci Med Sci</i> 2001; 56: M146–M156.
20. Yamamoto M, Mouillet G, Oguri A, Gilard M, Laskar M, Eltchaninoff H, et al. Effect of body mass index on 30- and 365-day complication and survival rates of transcatheter aortic valve implantation (from the FRench Aortic National CoreValve and Edwards 2 [FRANCE 2] registry). <i>Am J Cardiol</i> 2013; 112: 1932–1937.
21. Fukui S, Kawakami M, Otaka Y, Ishikawa A, Mizuno K, Tsuji T, et al. Physical frailty in older people with severe aortic stenosis. <i>Aging Clin Exp Res</i> 2016; 28: 1081–1087.
22. Alfredsson J, Stebbins A, Brennan JM, Matsouaka R, Afilalo J, Peterson ED, et al. Gait speed predicts 30-day mortality after transcatheter aortic valve replacement: Results from the Society of Thoracic Surgeons/American College of Cardiology transcatheter valve therapy registry. <i>Circulation</i> 2016; 133: 1351–1359.
23. Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Neumann FJ, et al. SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve. <i>Eur Heart J</i> 2017; 38: 2717–2726.
24. Takimoto S, Saito N, Minakata K, Shirai S, Isotani A, Arai Y, et al. Favorable clinical outcomes of transcatheter aortic valve implantation in Japanese patients: First report from the Post-Approval K-TAVI Registry. <i>Circ J</i> 2016; 81: 103–109.
25. Hioki H, Watanabe Y, Kozuma K, Nara Y, Kawashima H, Kataoka A, et al. Pre-procedural dual antiplatelet therapy in patients undergoing transcatheter aortic valve implantation increases risk of bleeding. <i>Heart</i> 2017; 103: 361–367.